Nephros (NEPH) Profit After Tax Growth (1y) (2011 - 2026)
Nephros (NEPH) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 16.74% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -123.42% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -25.08% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 9.23% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 54.57% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -188.83% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 20.96% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -113.49% |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | -74.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.91% |
| Dec 31, 2025 | -82.23% |
| Sep 30, 2025 | 84.15% |
| Jun 30, 2025 | 182.01% |
| Mar 31, 2025 | 430.18% |
| Dec 31, 2024 | 153.36% |
| Sep 30, 2024 | 200.55% |
| Jun 30, 2024 | 33.26% |
| Mar 31, 2024 | 44.77% |
| Dec 31, 2023 | 9.04% |
| Sep 30, 2023 | 94.23% |
| Jun 30, 2023 | 61.92% |
| Mar 31, 2023 | 84.44% |
| Dec 31, 2022 | 0.83% |
| Sep 30, 2022 | -293.27% |
| Jun 30, 2022 | -0.98% |
| Mar 31, 2022 | -266.29% |
| Dec 31, 2021 | 4.48% |
| Sep 30, 2021 | 20.75% |
| Jun 30, 2021 | 32.05% |